SKI Market

A+| A| A-|

Indian Indices

Sensex

77,316.54 652.33
( 0.85%)

Global Indices

Nasdaq

49,249.13 -82.20
(-0.17%)

Dow Jones

7,185.72 56.32
(0.79%)

Hang Seng

60,447.00 730.82
(1.22%)

Nikkei 225

10,387.94 -69.07
(-0.66%)

Forex

USD-INR

94.05 0.29
(0.31%)

EUR-INR

109.99 0.01
(0.01%)

GBP-INR

126.84 0.17
(0.14%)

JPY-INR

0.59 0.00
(0.16%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Lupin Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500257

INE326A01037

595.4947465

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LUPIN

18.98

104972.9

EPS(TTM)

Face Value()

Div & Yield %

120.95

0.52

Back

Hemang Resources reports standalone net loss of Rs 0.22 crore in the September 2025 quarter

Nov 17,2025

Net Loss of Hemang Resources reported to Rs 0.22 crore in the quarter ended September 2025 as against net loss of Rs 0.32 crore during the previous quarter ended September 2024. There were no Sales reported in the quarter ended September 2025 as against Rs 0.96 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	0	0.96	-100
OPM %	0	-34.38	-
PBDT	-0.22	-0.32	31
PBT	-0.22	-0.32	31
NP	-0.22	-0.32	31

77,316.54 652.33 ( 0.85%)

49,249.13 -82.20 (-0.17%)

7,185.72 56.32 (0.79%)

60,447.00 730.82 (1.22%)

10,387.94 -69.07 (-0.66%)

94.05 0.29 (0.31%)

109.99 0.01 (0.01%)

126.84 0.17 (0.14%)

0.59 0.00 (0.16%)